Previous close | 38.94 |
Open | 39.80 |
Bid | 39.20 |
Ask | 43.50 |
Strike | 220.00 |
Expiry date | 2026-01-16 |
Day's range | 38.94 - 39.80 |
Contract range | N/A |
Volume | |
Open interest | 131 |
Investing.com -- There is a higher potential for downside than upside in Biogen Inc's (NASDAQ:BIIB) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202.
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...